Abstract:Purpose: Advanced age is the largest risk factor for age-related macular degeneration (AMD). Sumoylation is a reversible post-translational modification that conjugates small peptide, small ubiquitin-like modifier (SUMO), to a target protein. Dysregulation of sumoylation is recently found to be critically involved in several age-related disorders. However, the effects of sumoylation during retina senescence and aging remains elusive. This study is aimed to investigate the function and regulation of sumoylation pathway in the aging retina and premature senescent retinal pigment epithelial (RPE) cells. Methods: 1.5- and 10-month C57/B6 mice were used for comparative aging study. Both ARPE primary cultures and ARPE-19 cells were used for assay systems. The qRT-PCR was used for analysis of mRNA expression. Western blot and immunofluorescence were used to analyze the protein expression. Cell flow cytometry was used for cell cycle progression analysis. RPE barrier function and senescent-associated beta-galactosidase (SA beta-gal) activity were analyzed to measure cellular senescence. Results: We show that the expression of SUMO enzymes and global protein sumoylation were downregulated in the aging mouse retina, and in the oxidative stress (OS) -induced premature senescent RPE cells. Dramatical altered distribution of SUMO E1, E2 and E3 enzymes were observed during RPE senescence. Inhibition of sumoylation alleviated OS-induced cell senescence in RPE cells, as indicated by decreased p21 and p53 expression and decreased percentage of cell cycle arrest at G(0)/G(1 )phase. Intriguingly, inhibition of SUMO E1 repressed the expression of proinflammatory cytokine and chemokine in the premature senescent RPE cells. However, inhibition of sumoylation did not prevent DNA damage during the OS-induced RPE senescence process. Conclusions: Our data indicate sumoylation critically regulates retina and RPE aging and that targeting sumoylation process may provide potential therapeutic strategy for AMD treatment.

Sumoylation in Cellular Senescence and Aging

Inhibition of Sumoylation Alleviates Oxidative Stress-induced Retinal Pigment Epithelial Cell Senescence and Represses Proinflammatory Gene Expression.

Role and mechanism of post-translational SUMOylation in atherosclerosis

Sumoylation in Lens Differentiation and Pathogenesis

DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.

[Sumoylation and Its Role in Hematological Disease].

Q 7 A Progress in SUMO modification research

Research progression in post-translational protein modification sumoylation in cancer

Sumoylation as an Emerging Target in Therapeutics against Cancer.

Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases

Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells

Sumoylation As an Emerging Target in Therapeutics Against Cancer

Protein SUMOylation and disease

Protein modification by SUMO.

SUMO Modification in Apoptosis

SUMO and the robustness of cancer

The post-translational modification, SUMOylation, and cancer (Review)

Post-Translational Modification of SUMOylation and Cancer: A Brief Review

Signalling mechanisms and cellular functions of SUMO

Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer

SUMOylation modification-mediated cell death